RITUXIMAB is a Schedule H drug.
Category: CD20 MONOCLONAL ANTIBODIES
Drug Classification
OFATUMUMAB
OFATUMUMAB is a Schedule H drug.
IBRITUMOMAB TIUXETAN
IBRITUMOMAB TIUXETAN is a Schedule H drug.
OBINUTUZUMAB
OBINUTUZUMAB is a Schedule H drug.
भाषा बदलें: हिंदी में
Drug Classification
RITUXIMAB is a Schedule H drug.
OFATUMUMAB is a Schedule H drug.
IBRITUMOMAB TIUXETAN is a Schedule H drug.
OBINUTUZUMAB is a Schedule H drug.